G13.8
Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere
Clinical Classification Guidelines
Code First
- underlying disease
Medical Intelligence & Overview
ICD-10 code G13.8 refers to systemic atrophy primarily impacting the central nervous system (CNS). This condition involves a widespread degeneration or wasting away of nerve tissues within the brain and spinal cord. It is categorized under diseases where atrophy is a significant feature but occurs in conjunction with other underlying conditions. The diagnosis of this condition highlights the importance of understanding neurological decline and its impact on overall health and functionality.
Causes & Symptoms
Clinical Causes: Progressive neurodegenerative diseases such as Alzheimer's or Parkinson's disease Autoimmune disorders affecting nervous tissues Chronic infections that involve the central nervous system Genetic or hereditary neurological conditions Exposure to neurotoxic substances or chemicals Vascular disorders impacting blood supply to the CNS Certain metabolic or systemic illnesses that lead to nerve tissue damage
Key Symptoms: Gradual decline in cognitive functions and memory loss Muscle weakness or paralysis in parts of the body Coordination and balance issues Difficulty in speaking or swallowing Sensory deficits such as numbness or tingling Behavioral and personality changes Seizures in some cases Loss of voluntary control over bladder or bowels
Diagnostic & Treatment
Diagnosis Path: Diagnosing G13.8 involves a combination of medical history review, neurological examinations, imaging studies such as MRI or CT scans, and laboratory tests to identify underlying causes. Neuropsychological assessments may also be conducted to evaluate cognitive decline. Since the condition signifies systemic atrophy, findings typically demonstrate extensive nerve tissue loss. Accurate diagnosis often requires ruling out other neurological or systemic illnesses that can mimic similar symptoms.
Treatment Protocols: Medication to control neurological symptoms, such as antispasmodics or cognitive enhancers Physical, occupational, and speech therapy to maintain functionality and quality of life Nutritional support to address deficiencies and improve systemic health Supportive measures for mobility and daily activities Management of associated conditions like seizures or behavioral issues Research-based interventions, including clinical trials, for disease modification
Clinical Advice & FAQs
Billing Guidance
Is G13.8 a billable ICD-10 code?
Yes, G13.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G13.8?
Clinical documentation must specify the nature of Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere and any associated comorbidities for accurate reporting.
Cite this Clinical Reference